Pnc Financial Services Group, Inc. Blueprint Medicines Corp Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,251 shares of BPMC stock, worth $114,616. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,251
Previous 1,136
10.12%
Holding current value
$114,616
Previous $122,000
5.74%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$612 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$609 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$494 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$363 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$253 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.47B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...